Renaissance Venture Capital

Renaissance Venture Capital Management, Inc. is a venture capital firm based in Ann Arbor, Michigan, founded in 2008. The firm specializes in both direct investments in early, mid, and late-stage ventures, as well as fund of funds investments, primarily targeting venture capital funds. Renaissance focuses on investing in companies located in the United States, with a particular emphasis on Michigan, and seeks co-investment opportunities in emerging Michigan companies. Typically, the firm invests between $0.5 million and $1 million in its portfolio companies. Additionally, Renaissance operates another fund focusing on larger investments of $3 to $7 million per company. The firm is committed to fostering economic growth through its investments in the venture capital sector.

Vince Nystrom

Principal, Business Development

Jeff Rinvelt

Partner

Christopher Rizik

Chief Executive Officer and Fund Manager

Christopher Rizik

Chief Executive Officer and Fund Manager

12 past transactions

Strata Oncology

Series C in 2021
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Autobooks

Series B in 2021
Autobooks, Inc. specializes in providing integrated payment and accounting software designed for small businesses, delivered through financial institutions. Founded in 2015 and based in Detroit, Michigan, the company offers an intelligent, cloud-based accounting platform that seamlessly connects bank accounts with essential financial tools. This integration helps to expedite cash flow, streamline account reconciliation, and support business growth. Autobooks provides a range of products, including applications for invoicing, bill payment, merchant services, treasury solutions, and automated accounting and bookkeeping. Originally known as Automated Booking, Inc., the company rebranded in March 2018 to reflect its focus on offering a comprehensive financial solution.

Strata Oncology

Series B in 2018
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Next Coast Ventures

Private Equity Round in 2017
Next Coast Ventures is a venture capital firm based in Austin, Texas, established in 2015. The firm focuses on providing early-stage capital to high-growth technology startups, particularly in emerging markets. Next Coast Ventures partners with entrepreneurs who are building innovative companies and leverages macro trends to shape its investment strategy. In addition to financial support, the firm offers hands-on resources and guidance through its extensive industry network and a venture partner program, drawing on the founders' own entrepreneurial experiences to foster the growth of its portfolio companies.

Cirius Therapeutics

Series A in 2017
Cirius Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and metabolic diseases. Its lead product candidate MSDC-0602K, is an oral small molecule that is in Phase 2b clinical trial being developed to treat nonalcoholic steatohepatitis with fibrosis. Cirius Therapeutics, Inc. was formerly known as Octeta Therapeutics, LLC and changed its name to Cirius Therapeutics, Inc. in March 2017. The company was founded in 2015 and is headquartered in San Diego, California.

Millendo Therapeutics

Series B in 2016
Atterocor, Inc. focuses on research and development of therapeutics for adrenal disease. Atterocor, Inc. was incorporated in 2012 and is based in Ann Arbor, Michigan.

ArborMetrix

Series B in 2014
ArborMetrix, Inc. specializes in data analytics and technology solutions aimed at enhancing outcomes and advancing research within the healthcare industry. The company offers a platform that facilitates data collection and integration, performance measurement, and analytics, along with comprehensive database administration. Its solutions include EpisodeMetrix, which analyzes episode costs to help healthcare payers and providers optimize networks and manage care costs, and RegistryMetrix, designed for creating tailored clinical registries. Additionally, SurgicalMetrix provides insights into the performance of surgical groups by integrating various clinical and operational data. ArborMetrix’s offerings also encompass clinical quality improvement, patient and provider engagement, value-based reimbursement, and clinical research. The company serves a diverse range of clients, including specialty societies, medical device manufacturers, pharmaceutical companies, and health systems across the United States. Founded in 2011, ArborMetrix is headquartered in Ann Arbor, Michigan.

Swift Biosciences

Series B in 2013
Swift Biosciences Inc. is a biotechnology company based in Ann Arbor, Michigan, specializing in the development and commercialization of next-generation sequencing (NGS) library preparation kits for genomics and clinical research. The company offers a comprehensive range of products, including RNA library kits, amplicon panels, hybridization capture kits, and specialized kits for cancer gene profiling and COVID-19 testing. Swift Biosciences aims to streamline NGS sample preparation processes through innovative reagents and protocols, enhancing the usability of data obtained from sequencing instruments. Its offerings cater to various applications such as whole-genome sequencing, metagenomics, and the analysis of circulating tumor cells. The company operates through a network of distributors across the Asia Pacific, Europe, the Middle East, and South America, and was incorporated in 2009.

Fidelis SeniorCare

Series A in 2013
Fidelis SeniorCare, Inc., a managed care company, develops and administers health plans for assisted living residents in Michigan, North Carolina, and Texas. The company offers Medicare advantage special needs plans to cover the health needs of seniors living in nursing homes and assisted living communities; and individuals who require specialized healthcare. Its plans cover on-site primary care team visits, part D prescription drugs, monitoring and managing prescribed medications, transportation to the hospital or physician’s office, and skilled nursing services during a covered Medicare stay; preventive care, screening, vision/dental/hearing, and podiatry services; and emergency room, ambulance, and urgent care services. The company was founded in 2004 and is based in Schaumburg, Illinois.